España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Imunon
IMNN
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.45
0.04
2.84%
At Close: -
$1.36
-0.09
-6.21%
After Hours: Jul 12, 4:50 PM EDT
15 minutes delayed
Get Report
Comment
Imunon (IMNN) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Imunon (NASDAQ:IMNN) Stock
Imunon Stock (NASDAQ: IMNN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, June 24, 2024
IMUNON Reports Database Lock For Phase 2 OVAT...
Benzinga Newsdesk
Wednesday, June 05, 2024
IMUNON Announces First Participants Have Been...
Benzinga Newsdesk
Wednesday, May 15, 2024
Imunon Inc. Files For Mixed Shelf Offering Up...
Benzinga Newsdesk
Imunon Abstract On Phase 2 Study With IMNN-00...
Benzinga Newsdesk
Tuesday, May 14, 2024
HC Wainwright & Co. Maintains Buy on Imunon, ...
Benzinga Newsdesk
Monday, May 13, 2024
IMUNON Reports Site Activation For IMNN-101 P...
Benzinga Newsdesk
Imunon Q1 EPS $(0.52) Beats $(0.57) Estimate
Benzinga Newsdesk
Wednesday, May 08, 2024
IMUNON Appoints Stacy R. Lindborg As Presiden...
Benzinga Newsdesk
Friday, April 26, 2024
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Thursday, April 18, 2024
IMUNON's IND Application Cleared By FDA To Be...
Benzinga Newsdesk
Thursday, April 11, 2024
IMUNON Reports Compliance With Nasdaq Listing...
Benzinga Newsdesk
Wednesday, April 10, 2024
Imunon Files FormRW, Co Determined Not To Pur...
Benzinga Newsdesk
Friday, April 05, 2024
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Tuesday, April 02, 2024
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, April 01, 2024
Imunon shares are trading higher after Hc Wai...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Imunon, ...
Benzinga Newsdesk
Thursday, March 28, 2024
Imunon shares are trading higher after the co...
Benzinga Newsdesk
Imunon Q4 EPS $(0.52) Beats $(2.30) Estimate
Benzinga Newsdesk
Imunon Says $15.7M In Cash, Investments, And ...
Benzinga Newsdesk
Imunon FY2023 EPS $(2.16) Beats $(2.30) Estim...
Benzinga Newsdesk
Earnings Scheduled For March 28, 2024
Benzinga Insights
Wednesday, March 27, 2024
Preview: Imunon's Earnings
Benzinga Insights
Monday, March 25, 2024
IMUNON Receives $1.3M From Sale Of Its New Je...
Benzinga Newsdesk
Wednesday, March 13, 2024
HC Wainwright & Co. Reiterates Buy on Imunon,...
Benzinga Newsdesk
IMUNON Files IND Application To Begin Human Testing Of IMNN-101; Expects Enrollment In Phase 1 Proof-Of-Concept Study Of DNA-Based Vaccine Technology To Begin In Q2
Happy Mohamed
Tuesday, March 12, 2024
IMUNON President And CEO Corinne Le Goff Has ...
Benzinga Newsdesk
Thursday, February 29, 2024
Independent Lab Announces Results From IMUNON...
Benzinga Newsdesk
Wednesday, February 28, 2024
Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga Insights
Tuesday, February 27, 2024
Memorial Sloan Kettering Cancer Center Is Now...
Benzinga Newsdesk
Tuesday, November 14, 2023
Earnings Scheduled For November 14, 2023
Benzinga Insights
Imunon: Q3 Earnings Insights
Benzinga Insights
Imunon Q3 EPS $(0.37) Beats $(0.66) Estimate
Benzinga Newsdesk
Monday, November 13, 2023
Imunon's Earnings Outlook
Benzinga Insights
Wednesday, October 18, 2023
IMUNON Announces First Patient Enrolled In Ph...
Benzinga Newsdesk
Thursday, September 28, 2023
Stocks That Hit 52-Week Lows On Thursday
Benzinga Insights
Imunon Highlights Early Data From Lead Program In Ovarian Cancer
Vandana Singh
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
IMUNON Reports Interim Progression-Free Survi...
Benzinga Newsdesk
Tuesday, September 26, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
Friday, September 15, 2023
HC Wainwright & Co. Reiterates Buy on Imunon,...
Benzinga Newsdesk
Thursday, August 24, 2023
IMUNON Enters Into CRADA For Preclinical Stud...
Benzinga Newsdesk
Friday, August 11, 2023
HC Wainwright & Co. Reiterates Buy on Imunon,...
Benzinga Newsdesk
Thursday, August 10, 2023
Imunon Q2 EPS $(0.61) Beats $(0.70) Estimate;...
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights
Wednesday, August 09, 2023
Earnings Outlook For Imunon
Benzinga Insights
Monday, August 07, 2023
Preclinical Data Showing Strong Immunogenicity And Protection With IMUNON's PlaCCine DNA-Based Vaccines Modality Available Online On bioRxiv
Happy Mohamed
Tuesday, May 30, 2023
IMUNON Presents PlaCCine Preclinical Data At ...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch